Molecule
Azacitidine
19 brands of Azacitidine in stock, compared side by side.
We stock 19 brands of Azacitidine (injection, vial, and tablet; 5 strengths). The lowest per-unit price is USD $ 3.21, for Azatend O 300 Mg Tablet. Every brand listed is prescription-only: you can upload your prescription at checkout or from your account.
| Brand | Strength | Pack | Price | Per unit | Availability |
|---|---|---|---|---|---|
| Azadine 50 Mg Injection | 50 Mg | 1 Vial | USD $ 160.00 | — | In stock |
| Azafab 100 Mg Injection | 100 Mg | 1 Vial | USD $ 36.00 | — | In stock |
| Azacytin 100 Mg Injection | 100 Mg | 1 Vial | USD $ 62.00 | — | In stock |
| Azatirel 100 Mg Injection | 100 Mg | 1 Vial | USD $ 76.00 | — | In stock |
| Azadual 100mg Injection | 100 Mg | 1 Vial | USD $ 95.00 | — | In stock |
| Citaza 100 Mg Injection | 100 Mg | 1 Vial | USD $ 120.00 | — | In stock |
| Xpreza 100 Mg Injection | 100 Mg | 1 Vial | USD $ 120.00 | — | In stock |
| Azatend 100 Mg Injection | 100 Mg | 1 Vial | USD $ 120.00 | — | In stock |
| Azadine 100 Mg Injection | 100 Mg | 1 Injection | USD $ 320.00 | — | In stock |
| Azadine 150 Mg Injection | 150 Mg | 1 Vial | USD $ 480.00 | — | In stock |
| Mds O 200 Mg Tablet | 200 Mg | 14 Tablets | USD $ 96.67 | USD $ 6.91 | In stock |
| Azacytin 200 Mg Tablet | 200 Mg | 1 Vial | USD $ 147.00 | — | In stock |
| Azashine 200 Mg Tablet | 200 Mg | 14 Tablets | USD $ 178.00 | USD $ 12.71 | In stock |
| Bd Zadine 200 Mg Tablet | 200 Mg | 14 Tablets | USD $ 281.42 | USD $ 20.10 | In stock |
| Azatend O 200 Mg Tablet | 200 Mg | 14 Tablets | USD $ 323.60 | USD $ 23.11 | In stock |
| Azatend O 300 Mg Tablet | 300 mg | 14 Tablets | USD $ 45.00 | USD $ 3.21 | In stock |
| Xpreza 300 Mg Tablet | 300 mg | 14 Tablets | USD $ 148.42 | USD $ 10.60 | In stock |
| Azarest 300 Mg Tablet | 300 mg | 14 Tablets | USD $ 162.58 | USD $ 11.61 | In stock |
| Azashine 300 Mg Tablet | 300 mg | 14 Tablets | USD $ 267.00 | USD $ 19.07 | In stock |
About Azacitidine
Azacitidine is a hypomethylating agent used to treat myelodysplastic syndromes (MDS), acute myeloid leukaemia (AML), and chronic myelomonocytic leukaemia (CMML). It works by incorporating into DNA and RNA, inhibiting the enzyme DNA methyltransferase, which reverses abnormal gene silencing that drives blood cancer cell growth.
Marketed as Vidaza, azacitidine is administered by subcutaneous injection or intravenous infusion in cycles of seven days every 28 days. It was the first drug shown to improve overall survival in higher-risk MDS. Treatment typically continues for at least six cycles before response is assessed. Indian manufacturers produce azacitidine for injection in 100 mg vials.
At a glance
- Brands in stock
- 19
- Strengths
- 50 Mg / 100 Mg / 150 Mg / 200 Mg / 300 mg
- From
- USD $ 36.00